Merck Expert Decries FDA Fosamax Report

Law360, New York (June 21, 2010, 7:05 PM EDT) -- A Merck & Co. endocrinologist told jurors Monday that a report by a U.S. Food and Drug Administration employee used to further the case of Fosamax product liability plaintiff Shirley Boles is "full of errors."

Under cross-examination, Anne de Papp testified in the U.S. District Court for the Southern District of New York that the report — which indicated poor results associated with the osteoporosis drug for certain purposes — "is wrong."

"The person who wrote this got this wrong," she said, when questioned about it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.